The Efficacy of Botulinum Toxin vs. Corticosteroid for the Treatment of Refractory Plantar Fasciitis

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

August 23, 2022

Primary Completion Date

September 13, 2024

Study Completion Date

September 13, 2024

Conditions
Plantar Fasciitis
Interventions
DRUG

Botulinum Toxin A

20 units of Onabotulinum A in 200 µL of saline injected into the flexor digitorum brevis via ultrasound-guidance

DRUG

Dexamethasone

1 mL of 4 mg/mL dexamethasone with 2 mL of 1% lidocaine OR 1 mL of 4 mg/mL dexamethasone, 1 mL of 2% lidocaine and 1 mL saline injected into the plantar fascia

Trial Locations (1)

84148

VA Salt Lake City Health Care System, Salt Lake City

All Listed Sponsors
lead

Western Institute for Veterans Research

OTHER

NCT05367271 - The Efficacy of Botulinum Toxin vs. Corticosteroid for the Treatment of Refractory Plantar Fasciitis | Biotech Hunter | Biotech Hunter